ACADIA Pharmaceuticals Inc (MEX:ACAD)
MXN 362 (0%) Market Cap: 75.95 Bil Enterprise Value: 61.93 Bil PE Ratio: 11.51 PB Ratio: 3.47 GF Score: 73/100

ACADIA Pharmaceuticals Inc at Bank of America Healthcare Conference Transcript

May 16, 2024 / 04:20PM GMT
Release Date Price: MXN509
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

Joining us again at the Bank of America Healthcare Conference. I'm Tazeen Ahmad, I am of the senior SMid biotech analysts here at the bank. It's my pleasure to introduce our next company, ACADIA Pharmaceuticals. Presenting for ACADIA is Steve Davis, who is, of course, Chief Executive Officer. Steve, good morning. Thanks for joining us here in Las Vegas.

Stephen R. Davis
ACADIA Pharmaceuticals Inc. - President, CEO & Director

Oh, thanks much, Tazeen. Really pleased to be here. Also, I should mention I have with me this morning, Brendan Winslow, Brendan works in our finance group and has joined me today.

Questions & Answers

Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

Okay. Great. Hi Brendan.

Brendan Winslow;Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research &

Hi.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot